Goldman Sachs
CLOV icon

Goldman Sachs’s Clover Health Investments CLOV Stock Holding History

Goldman Sachs’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-640,000
Closed -$4.73M – 6483
2021
Q3 		$4.73M Buy
+640,000
New +$5.48M ﹤0.01% 3416

Other funds holding CLOV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Goldman Sachs's CLOV Position: Q2 2026 in Review

Goldman Sachs reduced its Clover Health Investments (CLOV) stake by 46% in Q2 2026, selling an estimated $3.38M and leaving 1,170,742 shares worth $6.13M. The position accounts for ﹤0.01% of the portfolio, ranked #3699.

Goldman Sachs first reported a position in CLOV in Q4 2020 and has held it in 23 quarters since. The position peaked at $7.95M in Q1 2025. 227 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.

  • Goldman Sachs held 1,170,742 shares of Clover Health Investments worth $6.13M as of Q2 2026.
  • Goldman Sachs sold 994,820 Clover Health Investments shares in Q2 2026, an estimated $3.38M.
  • Clover Health Investments made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #3699 holding.
  • Goldman Sachs first reported a position in Clover Health Investments in Q4 2020 and has held it in 23 quarters since.
  • Goldman Sachs's Clover Health Investments position peaked at $7.95M in Q1 2025.
  • 227 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.